Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MDWD | US
0.07
0.42%
Healthcare
Biotechnology
30/06/2024
24/04/2026
16.72
16.71
16.99
16.24
MediWound Ltd. a biopharmaceutical company develops manufactures and commercializes novel bio-therapeutic and non-surgical solutions for tissue repair and regeneration in United States Europe and internationally. It markets NexoBrid a biopharmaceutical product for the removal of eschar a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005 which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne Israel.
View LessPrice Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
37.8%1 month
49.0%3 months
39.0%6 months
39.4%-
-
10.93
-
-
-6.32
8.56
-0.07
-14.50M
180.35M
180.35M
-
-88.56
-
6.10
-75.66
13.70
6.28
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.96
Range1M
3.23
Range3M
3.83
Rel. volume
0.49
Price X volume
876.11K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Coherus BioSciences Inc | CHRS | Biotechnology | 1.75 | 193.69M | -0.57% | n/a | -354.71% |
| Lexeo Therapeutics Inc. Common Stock | LXEO | Biotechnology | 5.85 | 193.41M | -2.66% | n/a | 6.58% |
| Fennec Pharmaceuticals Inc | FENC | Biotechnology | 6.84 | 192.74M | 2.70% | 64.86 | -2193.44% |
| Caribou Biosciences Inc. | CRBU | Biotechnology | 2.13 | 192.47M | -5.75% | n/a | 8.80% |
| Century Therapeutics Inc. Common Stock | IPSC | Biotechnology | 2.22 | 188.07M | -1.77% | n/a | 25.38% |
| MONOPAR THERAPEUTICS | MNPR | Biotechnology | 53.2 | 187.28M | -0.08% | n/a | 0.00% |
| Codexis Inc | CDXS | Biotechnology | 2.62 | 185.83M | 3.97% | n/a | 69.22% |
| Bolt Technology Corp | BOLT | Biotechnology | 4.83 | 184.82M | 1.26% | n/a | 22.00% |
| Ovid Therapeutics Inc | OVID | Biotechnology | 2.6 | 184.53M | -2.99% | n/a | 18.40% |
| Immuneering Corporation Class A Common Stock | IMRX | Biotechnology | 6.04 | 179.11M | -1.47% | n/a | 6.50% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 11.3 | 181.44M | 2.73% | n/a | 286.96% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 36.11 | 103.70M | 0.00% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.11 | 99.53M | 1.16% | 9.09 | 39.79% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.765 | 73.67M | 1.69% | 14.48 | 7.10% |
| ILAG | ILAG | Building Products & Equipment | 3.9 | 70.43M | 6.56% | n/a | 5.48% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 21.77 | 33.16M | -2.81% | n/a | 204.46% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.57 | 11.01M | -3.37% | n/a | 58.43% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5165 | 7.55M | -0.67% | 0.03 | 16.03% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.38 | 3.52M | 0.23% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.199 | 1.89M | 1.38% | n/a | 19.98% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -6.32 | 0.53 | Cheaper |
| Ent. to Revenue | 8.56 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 10.93 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 39.01 | 72.80 | Lower Risk |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 180.35M | 3.66B | Emerging |